-
How Price Discrimination is Good for Global Health (Part 2): Patricia Danzon describes how the concept, despite its theoretical upside, ‘is not working very well’ in practice
?In Part 1 of her interview with NBHC, professor Patricia Danzon of The Wharton School, University of Pennsylvania laid out some of the advantages of differential pricing in pharmaceuticals. In Part 2, she describes how the concept works in practice, including the key role of politics in its implementation.
- Categories
- Education, Health Care
-
WHO: $1 billion needed to keep Ebola infections within the ‘tens of thousands’
The World Health Organization is pleading for a global investment of nearly $1 billion to fight the spread of Ebola, warning that the amount is merely the minimum needed to keep infections of the deadly virus "within the tens of thousands."
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
India Must Fix Its Drug Quality Problem
India’s newly elected Prime Minister Narendra Modi just launched his first official tour of the United States.
- Categories
- Health Care
- Region
- South Asia
- Tags
- public health
-
The Devastating Economic Impact of Ebola
As the Ebola crisis continues to take a toll on people’s lives and livelihoods in West Africa, the focus is increasingly not just on the health aspects of the crisis, but also on its social and economic consequences.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Rwandans Balk at Price of Improved Cooking Stoves
A campaign to persuade people in Rwanda to buy a new improved type of cooking stove - which uses less fuel and is less smoky - hasn't succeeded, according to the stoves' manufacturers.
- Categories
- Education, Health Care
- Region
- Sub-Saharan Africa
-
Dozens of children feared dead after being injected with ‘tainted’ measles vaccine in Syria
As many as 36 children were reported to have died excruciating deaths last night after receiving tainted measles vaccines under a UN-sponsored programme in the rebel-held north of Syria.
- Categories
- Health Care
- Region
- North Africa & Near East
-
Japanese Global Health Fund awards $33.5 million to develop vaccines, drugs for neglected diseases
The Global Health Innovative Technology Fund (GHIT Fund), a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, today announced seven grant investments totaling US$15.3 million to speed the development of promising drugs and vaccines to battle three insect-borne diseases—malaria, dengue and Chagas disease.
- Categories
- Education, Health Care
- Region
- Asia Pacific
-
Mobilizing against TB
Every year, more than one million people around the world die from tuberculosis, a disease that has been treatable and preventable for decades.
- Categories
- Health Care
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.